PROFITEERING IN PRESC DRUGS Senate SponsorsSen. Mattie Hunter-Jacqueline Y. Collins 1/11/2005SenateSession Sine Die New Act815 ILCS 505/2Zfrom Ch. 121 1/2, par. 262ZCreates the Profiteering in Prescription Drugs Act. Provides that a manufacturer, distributor, or labeler of prescription drugs engages in illegal profiteering if that manufacturer, distributor, or labeler (i) exacts or demands an unconscionable price, (ii) exacts or demands prices or terms that lead to an unjust or unreasonable profit, (iii) discriminates unreasonably against any person in the sale, exchange, distribution, or handling of prescription drugs dispensed or delivered in this State, or (iv) intentionally prevents, limits, lessens, or restricts the sale or distribution of prescription drugs in this State. Provides a right of action and a civil penalty for violation. Provides that violation is a violation of the Consumer Fraud and Deceptive Business Practices Act. Effective immediately. 2/5/2004SenateFiled with Secretary by Sen. Mattie Hunter 2/5/2004SenateFirst Reading 2/5/2004SenateReferred to Rules 2/10/2004SenateAdded as Chief Co-Sponsor Sen. Jacqueline Y. Collins 1/11/2005SenateSession Sine Die